Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Sarcoma, Endometrial Stromal × trebananib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 Gynecologic 1

Conditions

Glioblastoma 2 Brain Neoplasms 2 Sarcoma, Endometrial Stromal 1 Sarcoma 1 Prostatic Neoplasms 1 Ovarian Neoplasms 1 Oligodendroglioma 1 Neoplasms 1 Melanoma 1 Kidney Neoplasms 1 Hemangiosarcoma 1 Gliosarcoma 1 Glioma 1 Colorectal Neoplasms 1 Carcinoma, Renal Cell 1

Interventions

trebananib 1 selurampanel 1 saracatinib 1 Sunitinib 1 Postmortem Imaging 1 Magnetic Resonance Spectroscopy 1 High-Energy Shock Waves 1 Cyproheptadine 1 Biopsy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01210222 2018-02-23

Trebananib in Treating Patients With Persistent or Recurrent Endometrial Cancer

GOG Foundation

Phase 2 Completed

35 enrolled 9 charts

GynecologicSarcoma

Sarcoma, Endometrial Stromal

Data powered by HemOnc (CC BY 4.0) Colophon ⚡